Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.706 USD | -2.75% | -0.27% | -20.44% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.44% | 4.99M | |
+21.91% | 47.9B | |
+46.56% | 41.42B | |
-2.32% | 40.7B | |
-6.20% | 28.92B | |
+11.12% | 25.55B | |
-21.78% | 19.27B | |
-1.02% | 12.15B | |
+30.46% | 12.14B | |
-0.91% | 11.99B |
- Stock Market
- Equities
- ALZN Stock
- News Alzamend Neuro, Inc.
- Alzamend Neuro : Plans Phase 1/2 Alzheimer's Vaccine Candidate Trial Next Year After 'Positive' FDA Response; Shares Jump 47%